Analyser av Remedy Entertainment

Remedy: Quality comes with costs - Redeye

Redeye updates its estimates and valuation following Remedy’s H1 report, where we increase our cost estimates.

Redeye • 15 Aug 2023 08:37

Remedy Q2 2023: Critics already love Alan Wake 2 - Redeye

Redeye comments on Remedys Q2-report. Revenue was somewhat below our estimates while EBIT was clearly below.

Redeye • 11 Aug 2023 09:20

Remedy: Alan Wake approaching - Redeye

Redeye looks beyond the soft result in Q1 and starts looking forward to the strong pipeline of games in 2023-2025.

Redeye • 28 Apr 2023 13:09

Remedy: Weak quarter due to milestone timing - Redeye

Redeye comment on Remedy’s Q1 business review. Sometimes milestone payments do not adapt to the quarterly economy so well, which is shown in...

Redeye • 26 Apr 2023 10:33

Remedy: Well-equipped for accelerated investments - Redeye

Redeye has postponed the expected release of the free-to-play game codenamed Vanguard in its research update.

Redeye • 13 Feb 2023 08:10

Remedy: Q4 2022, Alan Wake 2 is getting closer - Redeye

Remedy reported a Q4 with revenue of EUR 13.6 million exactly in line with our estimates and an EBIT of EUR 2.

Redeye • 10 Feb 2023 09:32

Remedy: Lowered budget assumptions on key projects - Redeye

Redeye keeps its valuation range and base case unchanged despite a lowered revenue and EBIT expectation in 2023.

Redeye • 02 Dec 2022 08:59

Remedy Q3: Full-year projection intact despite somewhat weak quarterly revenue - Redeye

Revenues came in lower than expected during the quarter.

Redeye • 28 Oct 2022 09:37

Remedy: Discounted premium growth - Redeye

Redeye lowers its expectations and valuation on Remedy.

Redeye • 03 Oct 2022 08:34

Remedy: Postponed revenue streams should be undramatic - Redeye

Redeye will not make any immediate adjustments following the lowered guidance for 2022 from Remedy.

Redeye • 02 Aug 2022 08:12

Remedy: Estimate adjustments post Q1 - Redeye

Redeye has done some adjustments after the Q1 result.

Redeye • 19 May 2022 11:11

Remedy: Strong Cash flows from Development Fees - Redeye

Redeye comments on Remedy’s Q1 business review. Revenue was EUR 1.

Redeye • 13 May 2022 10:37

Remedy: Entering a Long Development Phase - Redeye

Redeye updates its financial projections in Remedy Entertainment.

Redeye • 21 Apr 2022 11:30

emedy: Strong Pipeline 2023 and Beyond and transfer to the Main List

Redeye comment on Remedy’s full-year report. Remedy posted an EBIT result in line with our estimated and somewhat higher revenue than expect...

Redeye • 11 Feb 2022 09:43

Remedy Entertainment: Stable Result and 10 million “Control” Players in Total - Redeye

Redeye comments on Remedy’s stable H1-report. Revenue amounted to EUR 17.

Redeye • 13 Aug 2021 09:12

Börskollen

För dig med koll på börsen